Ascendis Pharma AS (A71) — Cash Flow-to-Debt Ratio
Ascendis Pharma AS (A71) has a Cash Flow-to-Debt Ratio of -0.01x as of March 2026, meaning its operating cash flow of €-7.72 Million could theoretically repay 0% of its total liabilities (€1.52 Billion) in one year. See A71 financial flexibility score to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Ascendis Pharma AS Cash Flow-to-Debt Ratio (2016–2025)
Historical debt coverage capacity for Ascendis Pharma AS across 10 annual periods. For the full cash flow conversion analysis, see how efficiently does Ascendis Pharma AS generate cash.
Annual Cash Flow-to-Debt Ratio for Ascendis Pharma AS (2016–2025)
Year-by-year debt coverage analysis for Ascendis Pharma AS. Check cash flow quality index of Ascendis Pharma AS to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (EUR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.04x | €53.90 Million | €1.47 Billion | ▲ +115.4% |
| 2024 | -0.24x | €-306.20 Million | €1.29 Billion | ▲ +50.5% |
| 2023 | -0.48x | €-467.36 Million | €971.28 Million | ▲ +19.8% |
| 2022 | -0.60x | €-495.70 Million | €826.39 Million | ▲ +71.1% |
| 2021 | -2.07x | €-417.65 Million | €201.29 Million | ▼ -7.8% |
| 2020 | -1.92x | €-271.55 Million | €141.08 Million | ▲ +12.9% |
| 2019 | -2.21x | €-175.94 Million | €79.62 Million | ▲ +38.0% |
| 2018 | -3.57x | €-138.80 Million | €38.92 Million | ▲ +10.9% |
| 2017 | -4.00x | €-95.10 Million | €23.77 Million | ▲ +10.5% |
| 2016 | -4.47x | €-60.18 Million | €13.46 Million | — |